THE VALUE OF PMAPK AND PAKT IN HER2+BREAST CANCER WITH ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY

被引：0
|
作者：
Huang, L. [1 ,2 ]
Chen, T. [3 ]
Chen, C. [1 ,2 ]
Chen, S. [1 ,2 ]
Liu, Y. [1 ,2 ]
Wu, J. [1 ,2 ]
Shao, Z. [1 ,2 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China
[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China
[3] Shenzhen Sixth Peoples Hosp, Dept Thyroid & Breast Surg, Shenzhen, Peoples R China
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Yao, L.
    Liu, Y.
    Li, Z.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Xie, Y.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (06) : 1326 - 1331
  • [2] Docetaxel and anthracycline-based neoadjuvant chemotherapy in breast cancer
    Tiezzi, D. G.
    Andrade, J. M.
    Macchetti, A. H.
    Clagnan, W. S.
    Marana, H. R.
    Zola, F. E.
    Peria, F. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens
    Ibragimova, M. K.
    Kravtsova, E. A.
    Tsyganov, M. M.
    V. Litviakov, N.
    [J]. ACTA NATURAE, 2023, 15 (03): : 66 - 74
  • [4] Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Huang, Liang
    Chen, Tianwen
    Chen, Canming
    Chen, Sheng
    Liu, Yin
    Wu, Jiong
    Shao, Zhiming
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11 : 1 - 9
  • [5] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
    Vargas-Roig, L. M.
    Cuello-Carrion, F. D.
    Fernandez-Escobar, N.
    Daguerre, P.
    Leuzzi, M.
    Ibarra, J.
    Gago, F. E.
    Nadin, S. B.
    Ciocca, D. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Liang Huang
    Tianwen Chen
    Canming Chen
    Sheng Chen
    Yin Liu
    Jiong Wu
    Zhiming Shao
    [J]. World Journal of Surgical Oncology, 11
  • [7] The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer
    Schippinger, Walter
    Dandachi, Nadia
    Regitnig, Peter
    Hofmann, Gunter
    Balic, Marija
    Neumann, Rainer
    Samonigg, Hellmut
    Bauernhofer, Thomas
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (04) : 630 - 637
  • [8] Evolution of angiogenesis following anthracycline-based neoadjuvant chemotherapy in breast cancer
    Baena-Canada, Jose M.
    Gonzalez, Maria J. Palomo
    Arellano, Esperanza Arriola
    Requena, Maria J. Anon
    Rodriguez, Encarnacion Benitez
    [J]. MEDICINA CLINICA, 2008, 130 (19): : 721 - 725
  • [9] The Predictive Value of Serum Serum Her-2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy of Advanced Primary Breast Cancer
    Jeon, C.
    Lee, J. S.
    Min, W.
    [J]. CANCER RESEARCH, 2010, 70
  • [10] Clinical Implications of HER-2 and P53 in Taxane-Based and Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
    Xiaolan Wang~1 Fan Yao~1 Nan Liu~2 Yunfei Wu~1 Xinyu Zheng~1 Jiguang Li~1 Caigang Liu~1 Xueshan Qiu~2 Feng Jin1 Department of Surgical Oncology Department of General Surgery
    Department of Pathology
    [J]. Cancer Biology & Medicine, 2008, (06) : 424 - 428
12345